PPIG and brain disorder: Natural compounds causing potentiate pharmacokinetic drug interactions associated with the inhibition of CYP metabolism, renal excretion, and/or efflux transportation in the intestine and brain and causing synergistic pharmacodynamic drug interactions can be co-administered or formulated with drugs for the enhanced treatment of brain disorders.